ADIL
Price
$0.34
Change
-$0.13 (-27.66%)
Updated
Jun 27 closing price
Capitalization
5.29M
CLYM
Price
$1.18
Change
-$0.08 (-6.35%)
Updated
Jun 27 closing price
Capitalization
79.74M
51 days until earnings call
Interact to see
Advertisement

ADIL vs CLYM

Header iconADIL vs CLYM Comparison
Open Charts ADIL vs CLYMBanner chart's image
Adial Pharmaceuticals
Price$0.34
Change-$0.13 (-27.66%)
Volume$15.28M
Capitalization5.29M
Climb Bio
Price$1.18
Change-$0.08 (-6.35%)
Volume$3.6M
Capitalization79.74M
ADIL vs CLYM Comparison Chart in %
Loading...
ADIL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CLYM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ADIL vs. CLYM commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADIL is a Buy and CLYM is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (ADIL: $0.34 vs. CLYM: $1.18)
Brand notoriety: ADIL and CLYM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADIL: 163% vs. CLYM: 1444%
Market capitalization -- ADIL: $5.29M vs. CLYM: $79.74M
ADIL [@Biotechnology] is valued at $5.29M. CLYM’s [@Biotechnology] market capitalization is $79.74M. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADIL’s FA Score shows that 1 FA rating(s) are green whileCLYM’s FA Score has 1 green FA rating(s).

  • ADIL’s FA Score: 1 green, 4 red.
  • CLYM’s FA Score: 1 green, 4 red.
According to our system of comparison, both ADIL and CLYM are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADIL’s TA Score shows that 4 TA indicator(s) are bullish while CLYM’s TA Score has 2 bullish TA indicator(s).

  • ADIL’s TA Score: 4 bullish, 6 bearish.
  • CLYM’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, ADIL is a better buy in the short-term than CLYM.

Price Growth

ADIL (@Biotechnology) experienced а +36.55% price change this week, while CLYM (@Biotechnology) price change was -2.48% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

CLYM is expected to report earnings on Aug 19, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CLYM($79.7M) has a higher market cap than ADIL($5.29M). CLYM YTD gains are higher at: -34.444 vs. ADIL (-66.822). ADIL has higher annual earnings (EBITDA): -8.71M vs. CLYM (-50.37M). CLYM has more cash in the bank: 98.1M vs. ADIL (2.37M). ADIL has less debt than CLYM: ADIL (194K) vs CLYM (474K). ADIL (0) and CLYM (0) have equivalent revenues.
ADILCLYMADIL / CLYM
Capitalization5.29M79.7M7%
EBITDA-8.71M-50.37M17%
Gain YTD-66.822-34.444194%
P/E RatioN/AN/A-
Revenue00-
Total Cash2.37M98.1M2%
Total Debt194K474K41%
FUNDAMENTALS RATINGS
ADIL: Fundamental Ratings
ADIL
OUTLOOK RATING
1..100
94
VALUATION
overvalued / fair valued / undervalued
1..100
33
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
97
P/E GROWTH RATING
1..100
58
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ADILCLYM
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
87%
Bullish Trend 3 days ago
77%
Momentum
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
85%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
84%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
78%
Advances
ODDS (%)
Bullish Trend 20 days ago
79%
N/A
Declines
ODDS (%)
Bearish Trend 12 days ago
90%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
ADIL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CLYM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BKIRF0.08N/A
+4.38%
Black Iron Inc.
OROVY84.71N/A
N/A
Orient Overseas International Ltd.
KITAF0.94N/A
N/A
Kitanotatsujin Corporation
BGAOY1.90-0.05
-2.56%
Proximus Group
PVLUF100.19-5.10
-4.84%
Partners Value Invts LP

ADIL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ADIL has been loosely correlated with VANI. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if ADIL jumps, then VANI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADIL
1D Price
Change %
ADIL100%
-28.67%
VANI - ADIL
37%
Loosely correlated
+0.76%
CLYM - ADIL
34%
Loosely correlated
-6.35%
GDTC - ADIL
30%
Poorly correlated
+1.30%
VTVT - ADIL
28%
Poorly correlated
-6.82%
JAGX - ADIL
26%
Poorly correlated
-7.75%
More

CLYM and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLYM has been loosely correlated with ABOS. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if CLYM jumps, then ABOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLYM
1D Price
Change %
CLYM100%
-6.35%
ABOS - CLYM
42%
Loosely correlated
-7.44%
GBIO - CLYM
38%
Loosely correlated
-15.40%
RXRX - CLYM
38%
Loosely correlated
-6.85%
CRSP - CLYM
37%
Loosely correlated
N/A
PDSB - CLYM
36%
Loosely correlated
-2.76%
More